The Covid-19 pandemic has created a big social emergency, and research progress is the only solution to face it and control it definitively. From the beginning of the crisis, IDIBELL has adapted to the new needs creating new lines of research to fight the virus and applying all the knowledge to the pandemic.
IDIBELL and its fight against Covid-19 Read More »
An IDIBELL-ICO study has identified that not only that antiangiogenic chemotherapy can induce more aggressiveness and malignancy in kidney tumors, but also, they have identified a biomarker to predict in which patients this may happen. These discoveries are another step towards making cancer therapy more personalized every day.
Drs. Jordi Carratalà, the coordinator of the Infectious Diseases and Transplants Program, and Fernando Fernández Aranda, principal investigator of the Psychiatry and Mental Health Group, both from IDIBELL and the Bellvitge University Hospital, have recently won the respective chairs of the Faculty of Medicine and Sciences of the Health of the University of Barcelona (UB).
The validation of this cellular mechanism will permit the identification of patients who have developed resistance to standard treatments and the implementation of more personalized medicine for prostate cancer.
IDIBELL researcher Josep Maria Aran and his research group will receive 100,000 euros from the aid Product from the AGAUR agency of the Generalitat de Catalunya. They will study two molecules that act on the immune system as possible treatments for autoimmune diseases.
Funding to study new drugs against autoimmune diseases Read More »
The interaction of these two receptors leads to the inhibition of the dopaminergic pathway, which in this disorder is abnormally active. This discovery opens the door to the design of new drugs for the treatment of schizophrenia that acts on this interaction.
The project aims to create online courses that help pre-doctoral researchers to acquire transversal skills for the future of their careers.
IDIBELL receives european funding to promote open science and innovation Read More »
Although polyphenols have shown anticarcinogenic activity in previous in vitro studies, the epidemiological study led by IDIBELL and the ICO has found no association between their concentration in blood and thyroid cancer.
A group of researchers from IDIBELL, CIBERSAM and the Hospital de Bellvitge have identified changes in the connection between the frontal cortex and subcortical regions in girls and boys with mild symptoms of obsessive-compulsive disorder (OCD).
Results could inform discussions on food packaging labels across Europe, say researchers. The study has the participation of Antonio Agudo and has been published in the journal The BMJ.
